Literature DB >> 3097410

Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.

I A Hughes.   

Abstract

The neonatal presentation of congenital adrenal hyperplasia is either virilization of females or salt loss in both sexes. Early diagnosis is based on the rapid measurement of plasma 17 alpha-hydroxyprogesterone. Milder forms of congenital adrenal hyperplasia can present later in life with abnormalities of somatic or sexual development. The majority of cases of congenital adrenal hyperplasia are clinically diagnosable in the first 2-3 weeks of life: the need for screening for the remaining missed cases and the late onset types remains to be established.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097410     DOI: 10.1007/bf01800865

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.

Authors:  J F Murphy; B G Joyce; J Dyas; I A Hughes
Journal:  Arch Dis Child       Date:  1983-07       Impact factor: 3.791

Review 2.  Congenital and acquired disorders of the adrenal cortex.

Authors:  I A Hughes
Journal:  Clin Endocrinol Metab       Date:  1982-03

3.  Pseudohypoaldosteronism: severe salt wasting in infancy caused by generalized mineralocorticoid unresponsiveness.

Authors:  M O Savage; I G Jefferson; M J Dillon; P J Milla; J W Honour; D B Grant
Journal:  J Pediatr       Date:  1982-08       Impact factor: 4.406

4.  Maternal and amniotic fluid 17 alpha-hydroxyprogesterone levels during pregnancy: diagnosis of congenital adrenal hyperplasia in utero.

Authors:  M Nagamani; P G McDonough; J O Ellegood; V B Mahesh
Journal:  Am J Obstet Gynecol       Date:  1978-04-01       Impact factor: 8.661

Review 5.  Neonatal endocrine and metabolic emergencies.

Authors:  I A Hughes; P A Davies
Journal:  Clin Endocrinol Metab       Date:  1980-11

6.  Plasma 17OH-progesterone concentrations in newborn infants.

Authors:  I A Hughes; D Riad-Fahmy; K Griffiths
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

7.  Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by amniotic fluid steroid analysis.

Authors:  I A Hughes; K M Laurence
Journal:  Prenat Diagn       Date:  1982-04       Impact factor: 3.050

8.  A rapid assay for 17 alpha OH-progesterone in plasma, saliva and amniotic fluid using a magnetisable solid-phase antiserum.

Authors:  J Dyas; G F Read; T Guha-Maulik; I A Hughes; D Riad-Fahmy
Journal:  Ann Clin Biochem       Date:  1984-09       Impact factor: 2.057

9.  Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening.

Authors:  R M Lebovitz; R M Pauli; R Laxova
Journal:  Am J Dis Child       Date:  1984-06

10.  Congenital adrenal hyperplasia--a clinical and genetic survey. Are we detecting male salt-losers?

Authors:  L Murtaza; J R Sibert; I Hughes; I C Balfour
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

View more
  2 in total

1.  Review of CAH screening programmes and the Scottish experience.

Authors:  A M Wallace
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Value of selective screening for congenital adrenal hyperplasia in Hungary.

Authors:  J Sólyom; I A Hughes
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.